Skip to main content

Closed

CMND: Clearmind Medicine Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-69.9%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage-461.7×

Current ratio4.79×

Clearmind Medicine Inc.

CMNDNASDAQ Capital Market·USD·Closed

Clearmind Medicine Inc.

CMNDNASDAQ·USD·Closed

$1.69

+4.32%

$1.69

+$0.07 (4.32%)

52W Range

0thpctl

Volume

0.04×avg

Mkt Cap

2.51MUSD

P/E

-0.1TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.04×avg

Market Cap

2.51MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings